Literature DB >> 2370109

Characterization and growth in human macrophages of Mycobacterium avium complex strains isolated from the blood of patients with acquired immunodeficiency syndrome.

P R Meylan1, D D Richman, R S Kornbluth.   

Abstract

Strains of the Mycobacterium avium complex (MAC) yield opaque and transparent colonial variants when cultivated in vitro. The transparent variants are more virulent than the opaque for animals, but little is known about the respective roles of these colonial variants in humans. To assess which variant infects humans, various blood fractions from eight patients with MAC bacteremia were plated directly onto 7H10 agar. In cell fractionation studies, all the M. avium complex CFU were associated with leukocytes and none were found free in plasma. All colonies on the primary culture plate exhibited the transparent phenotype. However, during subculture in 7H9 broth or on Lowenstein-Jensen agar, opaque variants appeared in seven of eight strains. Isogenic pairs of transparent and opaque variants were prepared and used to infect in vitro human monocyte-derived macrophages from healthy seronegative individuals. Transparent variants invariably grew inside macrophages, but only one of seven opaque variants did so. These observations indicate that the bacteremia of M. avium complex in acquired immunodeficiency syndrome patients consists exclusively of the transparent variants, perhaps because these variants are able to multiply inside macrophages. In contrast, opaque variants appear after in vitro subculture and are controlled by human macrophages, consistent with their reduced virulence in animals.

Entities:  

Mesh:

Year:  1990        PMID: 2370109      PMCID: PMC258856          DOI: 10.1128/iai.58.8.2564-2568.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Effect of temperature on the rate of the transparent to opaque colony type transition in Mycobacterium avium.

Authors:  C L Woodley; H L David
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

2.  Susceptibilities of transparent, opaque, and rough colonial variants of Mycobacterium avium complex to various fatty acids.

Authors:  H Saito; H Tomioka
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

3.  Mycobacterium intracellulare. Maintenance of pathogenicity in relationship to lyophilization and colony form.

Authors:  F P Dunbar; I Pejovic; R Cacciatore; L Peric-Golia; E H Runyon
Journal:  Scand J Respir Dis       Date:  1968

4.  Pathogenicity of transparent, opaque, and rough variants of Mycobacterium avium in chickens and mice.

Authors:  W B Schaefer; C L Davis; M L Cohn
Journal:  Am Rev Respir Dis       Date:  1970-10

5.  Relationship of colonial morphology to virulence for chickens of Mycobacterium avium and the nonphotochromogens.

Authors:  J M Moehring; M R Solotorovsky
Journal:  Am Rev Respir Dis       Date:  1965-11

6.  Direct visualization of mycobacteria in blood culture.

Authors:  B G Moffie; J W Krulder; J C de Knijff
Journal:  N Engl J Med       Date:  1989-01-05       Impact factor: 91.245

7.  A simple method for counting adherent cells: application to cultured human monocytes, macrophages and multinucleated giant cells.

Authors:  A Nakagawara; C F Nathan
Journal:  J Immunol Methods       Date:  1983-01-28       Impact factor: 2.303

8.  Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents?

Authors:  N Rastogi; C Frehel; A Ryter; H Ohayon; M Lesourd; H L David
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

9.  Spontaneous and Induced Mutation in Mycobacterium avium.

Authors:  C McCarthy
Journal:  Infect Immun       Date:  1970-09       Impact factor: 3.441

10.  Plasmid deoxyribonucleic acid and translucent-to-opaque variation in Mycobacterium intracellulare 103.

Authors:  Y Mizuguchi; M Fukunaga; H Taniguchi
Journal:  J Bacteriol       Date:  1981-05       Impact factor: 3.490

View more
  18 in total

1.  Diagnosis of disseminated mycobacterial infection: testing a simple and inexpensive method for use in developing countries.

Authors:  F C Fandinho; B Grinsztejn; V G Veloso; M C Lourenço; E Werneck-Barroso; E João; S A Nogueira; L de S Fonseca
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

2.  Observed differences in virulence-associated phenotypes between a human clinical isolate and a veterinary isolate of Mycobacterium avium.

Authors:  K A Birkness; W E Swords; P H Huang; E H White; C S Dezzutti; R B Lal; F D Quinn
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Enhancement of innate immunity against Mycobacterium avium infection by immunostimulatory DNA is mediated by indoleamine 2,3-dioxygenase.

Authors:  T Hayashi; S P Rao; K Takabayashi; J H Van Uden; R S Kornbluth; S M Baird; M W Taylor; D A Carson; A Catanzaro; E Raz
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

4.  Tumour necrosis factor-alpha (TNF-alpha) in the host resistance to mycobacteria of distinct virulence.

Authors:  R Appelberg; A Sarmento; A G Castro
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

5.  Virulent Mycobacterium fortuitum restricts NO production by a gamma interferon-activated J774 cell line and phagosome-lysosome fusion.

Authors:  Tânia Regina Marques Da Silva; Juliana Ribeiro De Freitas; Queilan Chagas Silva; Cláudio Pereira Figueira; Eliana Roxo; Sylvia Cardoso Leão; Luiz Antônio Rodrigues De Freitas; Patrícia Sampaio Tavares Veras
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

6.  Dissemination of enteric Mycobacterium avium infections in mice rendered immunodeficient by thymectomy and CD4 depletion or by prior infection with murine AIDS retroviruses.

Authors:  I M Orme; S K Furney; A D Roberts
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

7.  Search for the molecular basis of morphological variation in Mycobacterium avium.

Authors:  S Prinzis; B Rivoire; P J Brennan
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

Review 8.  Mycobacterium avium complex: advances in therapy.

Authors:  D V Havlir
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

Review 9.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

10.  Activity of defensins from human neutrophilic granulocytes against Mycobacterium avium-Mycobacterium intracellulare.

Authors:  K Ogata; B A Linzer; R I Zuberi; T Ganz; R I Lehrer; A Catanzaro
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.